Dr Adil Daud | Professor of Hematology, Oncology and Director
U.C.S.F. Helen Diller Family Comprehensive Cancer Center

Dr Adil Daud, Professor of Hematology, Oncology and Director, U.C.S.F. Helen Diller Family Comprehensive Cancer Center

Adil Daud is an expert in the therapy and development of drugs for melanoma. His fellowship in medical oncology was at the Memorial Sloan Kettering Cancer Center and was a faculty member at the Moffitt Cancer Center in Tampa, Fl.  He is currently Professor of Medicine and Dermatology at the University of California, San Francisco. He is the director of the Melanoma Program at the Helen Diller Family Cancer Center. Over the last decade, he has been involved in several key clinical trials, focusing on novel targeted therapy and immunotherapy for melanoma and for other tumors. His recent research has focused on the microenvironment as it related to the immune system. 


Agenda Day 2 @ 08:40

Precision oncology needs data sharing: Integrating genomic and clinical data to advance patient care and understanding patient outcomes

  • Does decoding the genes of patients’ cancer help to accelerate the pace of discovery?
  • Is more sequencing, across large populations worthwhile?
  • How to combine all these data into one searchable pool?
  • How will this translate to better and more personalized vaccines or treatments for patients?
  • The paradigm of bringing multiple cancer centers together, connecting academics with industry and how to data share
  • The type of data sharing necessary to learn from the experience of patients that go through cancer immunotherapy

back to speakers